Document is current
Any future updates will be listed below
-
Authors
Abdin, Osama https://orcid.org/0000-0002-5471-2906
Kim, Philip M. https://orcid.org/0000-0003-3683-152X
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (RGPIN-2017-064, RGPIN-2017-064)
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-166008, PJT-166008)
- License Information
-
More Information
Article History
Received: 29 November 2023
Accepted: 30 May 2024
First Online: 27 June 2024
Competing interests
: P.M.K. is a co-founder and consultant to multiple companies, including Fable Therapeutics, TBG Therapeutics and Zymedi. The other author declares no competing interests.
